AbC-19™ Rapid Test by Abingdon Health
Place your order directly with the manufacturer.
The AbC-19™ Rapid Test is able to confirm that IgG antibodies to the full Spike protein have been produced after vaccination or following direct exposure to the SARS-CoV-2 virus.
The AbC-19™ Rapid Test can be deployed across multiple populations and has the potential to inform vaccination programmes and health policy. The test can do this by showing how COVID-19 infection spreads through communities, where any why immunity to COVID-19 might be developing and how mass-immunisation campaigns could be designed.
The AbC-19™ Rapid Test is delivered at point of care (POC) using a blood sample from a finger-stick puncture, with test results ready in just 20 minutes.
Why use the AbC-19™ Rapid Test?
- Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
- Sensitivity: 98.03%, Specificity: 99.56%*
- Minimal operator training required
- CE marked for use by healthcare professionals
- For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries
Product Overview
AbC-19™ Rapid Test
Manufacturer Abingdon Health | Available Worldwide
Be the first to review this product
.jpg.ashx?width=100&height=100&bgcolor=white)